![]()
|
|
||||||||
J. Biol. Chem., Vol. 276, Issue 46, 42893-42900, November 16, 2001
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
§,
,
,
,
,
From the
Unité d'Immuno-Allergie, Institut
Pasteur, 75724 Paris Cedex 15, France and the ¶ Molecular
Inflammation Section, NIAMS, National Institutes of Health,
Bethesda, Maryland 20892
Received for publication, April 20, 2001, and in revised form, September 11, 2001
| |
ABSTRACT |
|---|
|
|
|---|
Following activation through high affinity IgE
receptors (Fc Mast cells are specialized immune cells able to secrete a variety
of mediators stored in cytoplasmic granules and involved in
inflammatory and allergic responses (1). Upon activation, they can
discharge almost their entire granular content by compound exocytosis
(2, 3). A potent physiological stimulus for degranulation is the
antigen-dependent aggregation of IgE bound to high affinity IgE receptors (Fc The accumulated evidence demonstrates that during regulated exocytosis
calcium can act directly on the molecular machinery involved in
membrane fusion. An essential part of this machinery are SNARE proteins
(7). During neurotransmitter release at the synapse, SNAREs assemble
into an extremely stable multimeric core complex composed of one
v-SNARE2 (synaptobrevin or
vesicular-associated membrane protein = VAMP) and two
t-SNAREs2 (syntaxin 1 and SNAP25) (8-10). Complex
formation is thought to provide the necessary energy to bring together
the two opposing membranes and drive bilayer mixing. SNARE complex
formation is regulated by additional positive and negative effectors
(8, 10). These include small GTPases of the Rab3 family (8, 11, 12). In
mast cells, degranulation also depends on SNARE-mediated fusion but
instead utilizes SNAP23, a SNAP25 homolog and syntaxin 4 (13, 14) as
well as the calcium sensor synaptotagmin (15). Rab3D also plays an
important role in regulating the fusion process in mast cells (16, 17)
but the mechanism by which it exerts its role is unknown.
Rab proteins regulate membrane traffic in eucaryotic cells by
organizing the assembly of effector molecules (18, 19). Rab-mediated
functions include membrane tethering of organelles (20),
calcium-dependent fusion (21, 22), and movement of vesicles
along the cytoskeleton (23-25). While many Rab proteins are
ubiquitous, members of the Rab3 family are enriched in
regulated-secretion-competent cells (11, 12). They are comprised of
four isoforms (Rab3A, -B, -C, and -D). Rab3A, the best studied family
member is abundantly expressed in brain and neuroendocrine cells.
Absence of Rab3A in knock-out mice led to an enhancement of
neurotransmitter release (21). Rab3A appeared to act at a late step as
the pool of fusion-competent vesicles was unchanged. Its absence also
interfered specifically with calcium-regulated fusion as triggering via
a calcium-independent stimulus was not affected. Similar conclusions
for the calcium-dependent action of Rab3 have been drawn
from studies in adrenal chromaffin cells and Aplysia
cholinergic neurons (22, 26). In mast cells, the predominant isoform is
Rab3D, although Rab3A and Rab3B have also been detected (16, 27, 28).
Overexpression of WT Rab3D inhibited Fc Several Rab3 effectors have been described. Some, like calmodulin (29,
30), Rabphilin (31), Noc2 (32), or RIM (33), may be components of the
calcium-dependent mechanism of exocytosis. However, a
molecular understanding of their function in conjunction with Rab3 has
not been achieved. In the present study we report the discovery of a
Rab3D-associated kinase activity in RBL-2H3 mast cells. The activity or
possibly the association of this kinase, named here Rak3D, was calcium
regulated. Rak3D specifically phosphorylates syntaxin 4 thus decreasing
its capacity to bind SNAP23. Therefore, this kinase may provide the
link between Rab3D and the calcium dependence of SNARE complex
formation in regulated-secretion competent cells.
Cell Cultures and Transfections--
RBL-2H3, COS-7, and C57
cells (kindly provided by Dr. Dastych, International Institute of
Molecular and Cell Biology, Poland) were maintained in Dulbecco's
modified Eagle's medium-Glutamax medium (Life Technologies,
Inc., Eragny, France) supplemented with 10% fetal bovine serum, 100 IU/ml penicillin G, and 100 µg/ml streptomycin (Life Technologies,
Inc.) at 37 °C in a humidified 5% CO2 incubator. COS-7
cells were transfected by electroporation with 30 µg of
Rab3A-SR Antibodies and Other Reagents--
Anti-dinitrophenyl
(DNP)-specific immunoglobulin E (IgE), rabbit anti-syk antibodies and
affinity purified rabbit antibodies to Rab3D, syntaxin 4, and
glutathione S-transferase (GST) have been described (14, 16,
34). Rabbit anti-syntaxin 4 was also purchased from Alomone Labs
(Jerusalem, Israel). F(ab')2 fragment of
peroxidase-conjugated anti-rabbit and normal rabbit IgG were purchased
from Jackson ImmunoResearch Laboratories (West Grove, PA). The
pharmacological agents 4 Cell Stimulation and Immunoprecipitation--
RBL-2H3 cells were
either harvested by trypsinization or left adherent. For stimulation
experiments, RBL-2H3 or C57 mast cells were sensitized at 1-2.5 × 106 cells/ml with DNP-specific-IgE (1:200) in complete
medium containing 20 mM Hepes, pH 7.3, for 1 h at
37 °C. After a washing step, cells were resuspended in complete
medium, 20 mM Hepes, pH 7.3, and stimulated at
37 °C with 100 ng/ml DNP-HSA. The reaction was stopped by adding an
excess of ice-cold phosphate-buffered saline. Cells were solubilized in
lysis buffer (25 mM Pipes, pH 7.3, 150 mM NaCl,
5 mM KCl, 5 mM MgCl2, 1% Triton
X-100, 1 mM sodium orthovanadate (Sigma), 1000 units/ml
aprotinin (Sigma), 10 µg/ml pepstatin, 20 µg/ml leupeptin, 2 µM 4-(2-aminoethyl)benzenesulfonyl fluoride (all from
Alexis Inc., San Diego CA) at 5 × 107 cells/ml
(nonadherent cells) or by directly adding 1 ml of lysis buffer to
adherent cells before harvesting them by scraping. Postnuclear supernatants were prepared by centrifugation at 15,000 × g for 30 min and added to 5 µg of anti-Rab3D antibody or
normal rabbit IgG prebound to protein A-Sepharose beads and
immunoprecipitated for 2 h at 4 °C.
In Vitro Immune Complex Kinase Assay
(IVK)--
Immunoprecipitations were performed as above and washed
additionally two times in kinase buffer (25 mM Pipes, pH
7.3, 150 mM NaCl, 5 mM KCl, 5 mM
MnCl2, 5 mM MgCl2, 0.25% Triton
X-100). IVK was performed in 50 µl of kinase buffer containing 10 µCi of [ In-gel Kinase Assay (IGKA)--
Anti-Rab3D or normal rabbit IgG
immunoprecipitates were electrophoresed in a SDS-polyacrylamide gel
containing MBP (0.5 mg/ml). IGKA was performed as described (35).
Briefly, following electrophoresis, SDS was removed from the gel by
repeated washings in 50 mM Tris-HCl, pH 8, containing 20%
propanol-2. Proteins were denaturated in 8 M urea 1 h
at room temperature and renaturated overnight in 50 mM
Tris-HCl, pH 8, containing 5 mM Immunoblotting--
Proteins resolved on SDS-PAGE were
transferred to nitrocellulose membranes (Schleicher & Schuell, Dassel,
Germany) and blocked by incubation in Tris-buffered saline containing
0.1% Tween 20 and 5% nonfat dry milk. Blots were then incubated for
1 h at room temperature with primary antibodies (anti-Rab3D at 1 µg/ml and anti-syntaxin 4 at 1/600 dilution). After several washes,
peroxidase-labeled anti-rabbit IgGs (1:30,000 dilution) were used as
secondary antibodies and incubated for 1 h at room temperature.
The blots were developed using the enhanced chemiluminescence assay
(Amersham Pharmacia Biotech).
Assay of Recombinant Proteins--
The cytoplasmic domains of rat
syntaxin 24-265, syntaxin 34-263, and
syntaxin 44-273 were expressed as GST fusion
proteins using the pGEX-2TK vector (Amersham Pharmacia Biotech)
and purified as described (14). Thrombin (Roche Molecular Biochemicals,
Meylan, France) was used to cleave GST from soluble recombinant
syntaxin 4. Recombinant human GST-SNAP23 was a gift of Thierry Galli
(Institut Curie, Paris, France). Deletion mutants of syntaxin 4 were
generated by polymerase chain reaction amplification to obtain Ha- (aa
4-68), Ha/Hb- (aa 4-114), and Ha/Hb/Hc- (aa 4-166) domains fused to
GST.
In Vitro Binding Assay--
Soluble recombinant syntaxin 4 (10 µM) was phosphorylated in an IVK by Rak3D present in
anti-Rab3D immunoprecipitates (107 cell equivalents). For
binding to recombinant GST-SNAP23, soluble phosphorylated S4 (0.3 µM) was mixed in 300 µl of kinase buffer with
glutathione-Sepharose beads containing 2 µM GST-SNAP23.
The mixture was incubated 2 h at 4 °C with end-over-end
rotation. Beads were centifuged and the supernatant (unbound syntaxin
4) was recovered and an equal amount of 2 × SDS sample buffer was added. Beads were washed twice with 1 ml of kinase buffer and 60 µl
of sample buffer was added to recover bound syntaxin 4. Samples (bound
and free syntaxin 4) were boiled for 3 min and equal amounts of protein
were simultaneously resolved on two separate SDS-PAGE. Gels were
processed for PhosphorImager analysis or immunoblotting with
anti-syntaxin 4 antibody. Quantitation of phosphorylated and
immunoblotted syntaxin 4 species was carried out using ImageQuant and
NIH Image software, respectively. No binding was detectable to two
other GST fusion proteins (GST-VAMP3 and GST-VAMP8) in control experiments.
In Vivo Labeling with
[32P]Orthophosphate--
RBL-2H3 cells were treated as
described (36). Briefly, 2 × 106 RBL-2H3 cells were
incubated in phosphate-free medium for 3 h at 37 °C before
addition of 1 µg/ml IgE for 1 h at 37 °C, then labeled with
330 µCi/ml [32P]orthophosphate for 3 h at
37 °C. Cells were washed with phosphate-free medium and stimulated
with 100 ng/ml DNP-HSA for 5 min or left unstimulated. Ice-cold
phosphate-buffered saline was added to stop stimulation and cells were
lysed as described above. Syntaxin 4 and p72syk were
immunoprecipitated from stimulated and unstimulated cells. After
separation by SDS-PAGE and transfer onto a nitrocelullose filter, the
membrane was autoradiographed and subsequently blotted with
anti-syntaxin 4.
Phosphoamino Acid Analysis--
Phosphoamino acid analysis was
carried out according to a published procedure (37). Briefly, Rab3D was
immunoprecipitated and proteins were subjected to an IVK. The sample
was run on SDS-PAGE and transferred onto a polyvinylidene difluoride
membrane (HybondTM, Amersham Pharmacia Biotech). After a
short autoradiography the portion corresponding to labeled species was
excised. Bound protein was hydrolyzed in 6 M HCl for 1 h at 110 °C. The hydrolysate was dried, washed, and redissolved in
acetic acid/pyridine/water (10:1:189, v:v:v). Phosphoserine,
phosphothreonine, and phosphotyrosine standards (3 µg of each) were
dissolved in 2 µl of acetic acid/pyridine buffer. The phosphoamino
acids were separated at 1600 V for 20 min on a cellulose TLC in the
same buffer used to dissolve samples. Unlabeled phosphoamino acid
standards were detected with ninhydrin and labeled amino acids were
visualized by autoradiography.
A Ser/Thr Kinase Is Associated with Rab3D in RBL-2H3
Cells--
Several functional links between protein kinases and small
GTPases have been demonstrated making the search for protein kinases as
potential effectors of Rab3D particularly important. To identify such a
putative protein kinase we first examined whether the antibody we
generated to the Rab3D carboxyl-terminal divergent region could specifically immunoprecipitate the Rab3D isoform, as both Rab3A and
Rab3D are expressed in RBL-2H3, the mast cell line used in these
studies. COS-7 cells were transfected with cDNAs encoding Rab3A,
Rab3D, or the empty expression vector. Cell lysates were prepared and
proteins were immunoprecipitated and immunoblotted using the anti-Rab3D
antibody. As shown in Fig. 1A,
a band corresponding to the expected molecular mass of 27 kDa was only
detected in the Rab3D-transfected cells demonstrating that our antibody
could indeed immunoprecipitate Rab3D in a specific manner. We next
examined whether immobilized Rab3D was associated with a protein kinase activity by performing an IVK. A phosphorylated molecular species of
about 130 kDa (pp130) was consistently detected in anti-Rab3D immunoprecipitates but not in those immunoprecipitates where normal rabbit IgG was used (Fig. 1B). To determine whether this
phosphoprotein could represent a kinase, we first analyzed whether the
kinase activity associated with Rab3D was able to phosphorylate enolase and MBP, which are generic substrates for protein tyrosine and Ser/Thr
kinases, respectively. Fig. 2A
shows that MBP was strongly phosphorylated in this assay while enolase
remained unphosphorylated suggesting that the identified kinase
activity corresponds to a Ser/Thr kinase. This was further confirmed by
direct phosphoamino acid analysis that revealed that pp130 is
phosphorylated on Ser/Thr residues but not on Tyr (Fig. 2B).
The MBP protein was then used as a substrate in an IGKA to directly
assay whether pp130 has by itself kinase activity. Fig. 2C
shows the phosphorylated band that could be detected at a molecular
mass of around 130 kDa. This suggests that the pp130 protein has itself
kinase activity. Although this kinase activity appeared to be weak,
when compared with IVK, denaturation, and renaturation of the kinase
could likely affect the fraction of active kinase remaining in the
IGKA. Indeed, as stronger exposures revealed a background activity in
lanes of control IgG we quantitated the difference to Rab3D
immunoprecipitates using PhosphorImager analysis, which was found to be
more than 7-fold (see figure legend). Taken together, these results
indicate that a Ser/Thr kinase of ~130 kDa is associated with Rab3D
that we refer to in the following as Rak3D.
Fc Rak3D Specifically Phosphorylates Syntaxin 4 in Its
NH2-terminal Regulatory Domain--
One of the proposed
roles for Rab3 proteins is the calcium-dependent regulation
of membrane fusion. However, the molecular mechanisms are poorly
understood. As we found that Rak3D was calcium-regulated it was of
interest to determine whether it could directly phosphorylate SNARE
proteins. An IVK was performed in the presence of GST fusion proteins
containing the cytoplasmic domains of syntaxin 2, syntaxin 3, or
syntaxin 4. All of these syntaxins had been previously shown to be
phosphorylated by specific sets of kinases (40, 41). The results from a
representative IVK in the presence of 10 µM substrate are
shown in Fig. 4A.
Surprisingly, these results revealed a unique specificity for Rak3D, in
that it effectively phosphorylated GST-syntaxin 4 while not
phosphorylating GST-syntaxin 2 or 3. Because of the specificity of
Rak3D we tested a variety of other SNARE fusion proteins expressed in
RBL-2H3 cells including GST-SNAP23, GST-VAMP2, GST-VAMP3, and
GST-VAMP8. With the sole exception of syntaxin 4, all other tested
proteins failed to be phosphorylated by Rak3D under the conditions used
(data not shown). We also found that comparable to its
autophosphorylation and the phosphorylation of the exogenous substrate
MBP, the phosphorylation of GST-syntaxin 4 followed the same
receptor-dependent kinetics, with a pronounced down-regulation
at 3 min of stimulation (Fig. 4B). To shed some insight on
its unusual specificity for syntaxin 4 we wished to determine the site
of phosphorylation in syntaxin 4. We constructed a series of deletion
mutants (Fig. 4C) that allowed examination of the various
helices (Ha, Hb, and Hc) present in the NH2-terminal regulatory domain as well as the SNARE motif (H3 domain) as predicted from sequence alignment and the resolved crystal structure of syntaxin
1 (42) (Fig. 4C). Ten µM of the various
deletion mutants were subjected to an IVK in the presence of Rak3D.
Fig. 4C shows the phosphorylation pattern of the different
deletion mutants as well as a quantitative PhosphorImager analysis
summarizing several experiments. The results demonstrate that Rak3D is
able to phosphorylate syntaxin 4 at more than one site in the
NH2-terminal regulatory domain. Significant differences in
relative amount of phosphorylation were observed for both Hb and Hc in
the NH2-terminal regulatory domain. Sequence alignment
comparisons among the three syntaxins suggest that Ser-78 could
be one of the phosphorylated residues in Hb as it was the only serine
or threonine residue which was absent in syntaxin 2 and 3. These data
also corroborate our previous conclusion that Rak3D is a Ser/Thr kinase
because tyrosine residues are not present in Hb. Several candidate
residues that could account for specific phosphorylation of Hc in
syntaxin 4 are Thr-120, Ser-143, and Ser-146, because these are absent in the corresponding syntaxin 2 and 3 sequences.
Syntaxin 4 Phosphorylation by Rak3D Affects Its Interaction with
the t-SNARE SNAP23--
Although not located in the SNARE motif,
phosphorylation in the NH2-terminal regulatory domain of
syntaxin 4 may indirectly affect SNARE assembly due to induced
conformational changes or steric hindrance. We therefore assessed
whether phosphorylation by Rak3D could affect binding of syntaxin 4 to
one of its t-SNARE partners SNAP23. We designed a quantitative assay to
evaluate phosphorylated syntaxin 4 binding to SNAP23, taking into
account that only a small amount of added syntaxin 4 becomes
phosphorylated in the IVK. Indeed, preliminary experiments established
that less than 1% of the syntaxin 4 used in the kinase reaction was
phosphorylated (under limiting concentrations of Rak3D and
[ Syntaxin 4 Is Phosphorylated in RBL-2H3 Cells--
We finally
asked whether syntaxin 4 could be phosphorylated in vivo in
resting cells and whether this phosphorylation decreased as observed in
our in vitro experiments. RBL-2H3 cells were labeled with
[32P]orthophosphate and syntaxin 4 was immunoprecipitated
from resting and stimulated cells. Experiments shown in Fig.
6 revealed that syntaxin 4 is indeed
phosphorylated in resting cells in agreement with our in
vitro data. Its overall phosphorylation status, however, did not
seem dramatically affected by receptor engagement although stimulation
was successful as indicated by the increased phosphorylation of syk
tyrosine kinase.
Rab3 GTPases function in regulated-secretion competent cells by
limiting calcium-triggered membrane fusion mediated by SNARE proteins
(12, 21, 22). The relationship between the calcium signal obtained
after cell stimulation and Rab3 action remains poorly understood.
Nevertheless, recent evidence from studies both in yeast and mammalian
cells indicates that protein phosphorylation and dephosphorylation
represents an important mechanism that regulates SNARE assembly (40,
41, 43-45). Furthermore, it was demonstrated that small G proteins
from the Ras, Rho, and Rab families function together with
protein kinases to facilitate their actions (46-48). A well known
example is the Ras-dependent recruitment of Raf leading to
the activation of the mitogen-activated protein kinase cascade and gene
regulation (46). This prompted us to search for IgE-triggered phosphorylation events that could be associated with Rab3D, a regulator
of exocytosis in RBL-2H3 mast cells.
Using IVK we discovered a 130-kDa Ser/Thr-phosphorylated protein that
was consistently co-immunoprecipitated with Rab3D. After performing an
in-gel kinase assay in the presence of the generic substrate MBP we
found that a protein in this molecular weight range was the unique
Rab3D-associated protein that revealed kinase activity. This suggests
that pp130 represents by itself a Ser/Thr kinase that we have termed
here Rak3D. The activity was maximal in unstimulated cells and
decreased dramatically after Fc At this point we are unable to explain the relationship between the
kinase and the nucleotide-bound state of Rab3D. Attempts to isolate
Rak3D using GTP or GDP-bound recombinant GST-Rab3D fusion proteins have
been unsuccessful,3
suggesting that the granule membrane-localized Rab3D (28) most likely
requires lipid modification for this interaction, as is the case for
several Rab3 effectors (29, 50-52). Similarly, when we tried to
immunoprecipitate Rab3D from cells stably transfected with GTP-bound
mutant forms (N135I and Q81L) no changes were observed in the
Fc Although we have not formally demonstrated that the pp130 protein
(Rak3D) is the kinase responsible for phosphorylation of the t-SNARE
syntaxin 4 we found that the activity present in Rab3D immunoprecipitates specifically phosphorylates this t-SNARE and the
activity was similarly down-regulated after stimulation. Thus, as this
was the only identifiable activity in Rab3D immunoprecipitates it is
likely that pp130 represents the syntaxin 4 kinase. The t-SNAREs
syntaxin 2 and 3 were not phosphorylated, although the latter clearly
have been shown to be substrates of different kinases (40, 41).
Likewise, we did not detect phosphorylation of other SNARE proteins
expressed in RBL-2H3 cells by Rak3D, including the t-SNARE SNAP23 or
several v-SNAREs (VAMP2, VAMP3, and VAMP8). Thus, this unique
selectivity for syntaxin 4 suggests an important role for Rak3D in
regulating SNARE complex assembly. Interestingly, the plasma-membrane
localized syntaxin 4 (53, 54) was recently demonstrated to be a key
component of the fusion complex in mast cells and a variety of other
cells (14, 55, 56). Using a series of deletion mutants we established
that syntaxin 4 becomes phosphorylated at two different helices (Hb and
Hc) in the NH2-terminal regulatory domain (42, 57).
Comparison of sequence alignments with syntaxin 2 and 3 suggest several
phosphorylatable residues (Ser-78, Thr-120, Ser-143, and Ser-146) that
are solvent accessible in the homologous syntaxin 1 structure (42).
However, it appears that some of these sites (Ser-143 and Ser-146) may
become inaccessible when another regulator, the Munc18-3 protein is
bound to syntaxin 4 (58), whereas Thr-120 upon phosphorylation could
affect the interaction with the COOH-terminal SNARE motif.
Phosphorylation of syntaxins in the regulatory domain is not unique to
syntaxin 4 (40, 41). Syntaxin 1 was shown to be phosphorylated in the regulatory domain, but unlike syntaxin 4 its phosphorylation is located
close to the NH2 terminus before the Ha domain (59).
Our work also revealed that phosphorylation by Rak3D results in a
decrease of syntaxin 4 binding to its t-SNARE partner SNAP23. Several
arguments suggest that a phosphorylation-dependent
mechanism of SNARE complex assembly might be relevant in mast cell
exocytosis. (i) Clearly, the down-modulation of Rak3D can be observed
in intact cells and this correlates with the initiation of secretion
(16). (ii) In vivo labeling of RBL-2H3 cells with
[32P]orthophosphate has shown that syntaxin 4 is indeed
phosphorylated in unstimulated cells. (iii) There is also evidence that
secretion in mast cells is coupled to dephosphorylation by the protein
phosphatase 2A, which is recruited to the plasma membrane following
Fc How can these studies be interpreted in the context of the proposed
differential localization of Rab3D and syntaxin 4? Indeed, in
unstimulated cells, syntaxin 4 is plasma membrane localized while Rab3D
is localized to the granule compartment (28, 53, 54). It is possible
that the kinase is only active toward syntaxin 4 when
mediator-containing granules become tethered at the plasma membrane.
Thus, the tethered granule membrane is actively restricted from fusing
with the plasma membrane by Rak3D-dependent phosphorylation of syntaxin 4 (29). After stimulation Rab3D is found at the plasma
membrane (28) possibly as a Rab3D-Ca2+·CaM complex that
continues to control exocytosis, as previously suggested (30).
In conclusion, mast cells tethering of granules to the plasma membrane
has been observed (2, 3). Moreover, the compound exocytosis observed in
mast cells suggests that tethered granules are fully competent for
fusion as they are first to release their content upon encountering an
appropriate stimulus. Therefore, we suggest that phosphorylation of
syntaxin 4 in resting mast cells by Rak3D represents one of the
mechanisms that limits the assembly of closely tethered SNARE proteins
in resting cells. Cell activation and intracellular calcium increases
may counteract this Rab3D/phosphorylation-dependent fusion
clamp. Preliminary analysis suggest that Rak3D can be detected in other
secretion-competent tissues such as rat adipocytes and rat
pancreas.3 However, the identity of the kinase remains as
of yet unknown. Inhibitors of PKC as well as a variety of other kinases
(CaMKII, casein kinase, myosin light chain kinase, and protein kinase
A) did not affect Rak3D activity in our IVK.3 This
of course differs from the PKC-dependent syntaxin 4 phosphorylation, observed in activated human platelets (62) and thus we
are actively engaged in the identification of this kinase.
RI), mast cells release, within a few minutes, their
granule content of inflammatory and allergic mediators. Fc
RI-induced degranulation is a SNARE (soluble
N-ethylmaleimide attachment protein
receptors)-dependent fusion process. It is
regulated by Rab3D, a subfamily member of Rab GTPases. Evidence exists
showing that Rab3 action is calcium-regulated although the molecular
mechanisms remain unclear. To obtain an understanding of Rab3D function
we have searched for Rab3D-associated effectors that respond to
allergic triggering through Fc
RI. Using the RBL-2H3 mast cell line
we detected a Ser/Thr kinase activity, termed here Rak3D (from
Rab3D-associated kinase), because it was specifically co-immunoprecipitated
with anti-Rab3D antibody. Rak3D activity, as measured by its auto- or
transphosphorylation, was maximal in resting cells and decreased upon
stimulation. The down-regulation of the observed activity was blocked
with EGTA, but not with other degranulation inhibitors, suggesting that
its activity functions downstream of calcium influx. We found that
Rak3D phosphorylates the NH2-terminal regulatory domain of
the t-SNARE syntaxin 4, but not syntaxin 2 or 3. The phosphorylation of
syntaxin 4 decreased its binding to its partner SNAP23. Thus, we
propose a novel phosphorylation-dependent mechanism by
which Rab3D controls SNARE assembly in a calcium-dependent manner.
![]()
INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
RI).1
This activates both membrane-attached and cytoplasmic tyrosine kinases
that pave the way for the intracellular calcium increase that is
necessary for secretion (4-6).
RI-triggered degranulation,
an effect that was enhanced with preferentially GTP-bound mutants (16,
17).
![]()
EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
neo, Rab3D-SR
neo, and Sr
neo vectors, as previously
described (16). Cells were harvested 48 h later and processed for immunoprecipitation.
-phorbol 12-myristate 13-acetate (PMA),
wortmannin, EGTA, the kinase substrates myelin basic protein (MBP) and
enolase, glutathione-Sepharose beads, as well as dinitrophenyl-human
serum albumin (DNP-HSA) were purchased from Sigma. Ionomycin and
bisindolylmaleimide I were obtained from Calbiochem (San Diego, CA).
Protein A beads were from Amersham Pharmacia Biotech (Orsay, France).
-32P]ATP. Beads were washed two times and
eluted in 2 × SDS sample buffer. When exogenous substrates were
added, the reaction mixture was incubated in the presence of 10 µM substrate and following the IVK the total mixture was
resolved after addition of SDS sample buffer without a further washing
step. Quantitation of phosphorylated species was carried out on a
PhosphorImager (Molecular Dynamics) using ImageQuant software.
-mercaptoethanol and
0.04% Tween 20. The kinase assay was carried out by incubating the gel for 1 h at room temperature in kinase buffer containing a mixture of 20 µM ATP and 200 µCi of [
-32P]ATP.
The gel was washed with a 5% trichloroacetic acid solution containing
1% sodium pyrophosphate and analyzed on a PhosphorImager.
-Hexosaminidase Secretion--
Granule secretion of
the marker
-hexosaminidase in the presence of pharmacological agents
was analyzed as previously described (16). Pharmacological agents were
added 15 min before stimulation and were kept during the 30-min
stimulation period. The net percent inhibition was calculated in
comparison to cells incubated in the presence of vehicle only.
![]()
RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

View larger version (42K):
[in a new window]
Fig. 1.
Presence of a kinase activity in Rab3D
immunoprecipitates. A, specificity of an antibody to
Rab3D. Proteins from lysates of COS-7 cells transfected with empty,
Rab3A- or Rab3D-containing SR
neo vector were immunoprecipitated with
anti-Rab3D, resolved on 12% SDS-PAGE, transferred to nitrocellulose,
and probed with anti-Rab3D. The arrow indicates a specific
band corresponding to the expected molecular weight for Rab3D.
B, a kinase activity is associated with Rab3D
immunoprecipitates (IP). Proteins from lysates of resting
RBL-2H3 cells (107 cells/sample) were immunoprecipitated
with anti-Rab3D or normal rabbit IgG (rIgG) and subjected to an IVK in
the presence of [
-32P]ATP. After washing, labeled
proteins were resolved on a 10% SDS-PAGE, and analyzed using a
PhosphorImager. The arrow indicates the presence of a
Rab3D-associated 130-kDa phosphoprotein (pp130).

View larger version (27K):
[in a new window]
Fig. 2.
Characterization of Rab3D-associated kinase
activity. A, phosphorylation of the Ser/Thr kinase
substrate MBP, but not the tyrosine kinase substrate enolase by a
Rab3D-associated kinase activity. Rab3D was immunoprecipitated from
lysates of resting RBL-2H3 cells (107 cells/sample). An IVK
was performed in the presence of 10 µM enolase or MBP and
[
-32P]ATP. Phosphorylated proteins were resolved on
15% SDS-PAGE and analyzed on a PhosphorImager. B, pp130 is
phosphorylated on Ser/Thr residues. Following IVK pp130 was subjected
to phosphoamino acid analysis (PAA) as described under
"Experimental Procedures." Labeled amino acids were visualized by
autoradiography and compared with phosphoamino acid standards
represented schematically. C, identification of the pp130 as
the Rab3D-associated kinase (Rak3D) activity. Anti-Rab3D or normal
rabbit IgG immunoprecipitates from lysates of resting RBL-2H3 cells
were resolved on 10% SDS-PAGE containing 10 µM MBP as a
substrate. Separated proteins in the gel were renaturated as described
under "Experimental Procedures" and subjected to an IGKA in the
presence of 20 µM ATP and 200 µCi of
[
-32P]ATP. A labeled 130-kDa phosphoprotein
(arrow) was detected after PhosphorImager analysis.
Quantitation of the optical densities (arbitrary units) between normal
IgG and anti-Rab3D in the p130 area by PhosphorImager analysis revealed
a 7.4 ± 2.3 (mean ± S.D.) difference in three independent
experiments (experiment 1 = 10.0; experiment 2 = 5.8, and
experiment 3 = 6.8).
RI-dependent Modulation of Rak3D--
Rab3D has
been shown to inhibit mast cell degranulation stimulated via Fc
RI
(16, 17). As the signaling pathways between the initial stimulation
event and Rab3D are presently unknown we wished to analyze whether
receptor triggering could affect the kinase activity associated with
Rab3D. IgE-sensitized RBL-2H3 cells were challenged with antigen for
varying times and p130 autophosphorylation was determined. Fig.
3A shows a representative kinetic experiment as well as a quantitative analysis corresponding to
several experiments. The highest level of p130 autophosphorylation was
observed in resting cells. Interestingly, Fc
RI engagement for a
short time (3 min) led to a decrease in p130 autophosphorylation, which
then progressively increased again over longer periods of stimulation.
Similar results were obtained when we tested adherent RBL-2H3 cells or
C57 mast cells that grow in suspension thus excluding an effect of
trypsin treatment (data not shown). The capacity of the kinase to
transphosphorylate MBP is similarly down-modulated by Fc
RI
engagement (Fig. 3B). To examine whether the observed modulation of Rak3D was an early receptor-dependent event,
we stimulated cells with the calcium ionophore, iononomycin, and the
PKC activator, PMA, to bypass receptor-proximal events. The experiment
shown in Fig. 3C revealed that stimulation by PMA/ionomycin reproduced the kinetics observed upon stimulation through Fc
RI suggesting that the observed modulation of Rak3D is downstream of PKC-
and calcium-activated signals. PMA alone did not reproduce the same
kinetics (data not shown) indicating a calcium regulatory step. An
additional approach based on the use of pharmacological inhibitors was
undertaken to examine potential signals involved in the modulation of
Rak3D. RBL-2H3 cells were incubated in the presence of EGTA, which
blocks calcium influx, bisindolylmaleimide I, a broad spectrum
inhibitor of PKC (38), and wortmannin, a PI 3-kinase inhibitor (39). As
shown in Fig. 3D, only EGTA treatment abolished the observed
decrease of detectable Rak3D activity following Fc
RI triggering
although all pharmacological agents were nonpermissive for
degranulation at the applied doses. Altogether, these results are in
favor of a calcium-dependent modulation of Rak3D.

View larger version (48K):
[in a new window]
Fig. 3.
Rak3D activity is
Fc
RI-stimulation-dependent.
Fc
RI-modulation of Rak3D activity as revealed by the phosphorylation
of p130 (A) and MBP (B). IgE-sensitized RBL-2H3
cells were stimulated with DNP-HSA (100 ng/ml) for the indicated times.
Proteins in cell lysates were immunoprecipitated with either anti-Rab3D
or rabbit IgG as indicated and subjected to an IVK in the presence of
[
-32P]ATP (A) or 10 µM MPB
and [
-32P]ATP (B). Phosphorylated proteins
were separated on 10% SDS-PAGE and analyzed on a PhosphorImager. Equal
loading was verified by immunoblotting with anti-Rab3D. The histogram
in A represents a quantitative analysis of the relative
pp130 levels from six independent experiments (mean ± S.E.).
C, Rak3D activity is regulated downstream of calcium- and
PKC-activated signals. RBL-2H3 cells were stimulated with a combination
of PMA (20 nM) and ionomycin (1 µM) for the
indicated times. Proteins from cell lysates were immunoprecipitated
with anti-Rab3D and subjected to an IVK in the presence of
[
-32P]ATP. A PhosphorImager analysis of the 130-kDa
Rak3D activity is shown. Equal loading was verified by immunoblotting
with anti-Rab3D. D, Rak3D activity is regulated by calcium,
but not PKC or PI 3-kinase. IgE-sensitized RBL-2H3 cells were
preincubated in the presence of 5 mM EGTA, 2 µM bisindolylmaleimide I, and 100 nM
wortmannin. Cells were stimulated with DNP-HSA (100 ng/ml) for the
indicated times in the continuous presence of inhibitors. Cell lysates
were prepared, subjected to an IVK, and Rak3D phosphorylation was
analyzed as above. In parallel
-hexosaminidase release was measured
and percent inhibition (mean ± S.E.) was calculated as compared
with cells incubated in the presence of vehicle. Data are from at least
three independent experiments.

View larger version (32K):
[in a new window]
Fig. 4.
Rak3D specifically phosphorylates the Q SNARE
syntaxin 4. A, syntaxin 4 is a specific substrate of
Rak3D. Protein from lysates of resting RBL-2H3 cells (107
cells/sample) were immunoprecipitated with anti-Rab3D and subjected to
an IVK in the presence of [
-32P]ATP and 10 µM GST-syntaxin 2 (GST-syn2), GST-syntaxin 3 (GST-syn3), or GST-syntaxin 4 (GST-syn4).
Reaction products were resolved on 10% SDS-PAGE and analyzed using a
PhosphorImager and Coomassie Blue staining. B,
phosphorylation of GST-syntaxin 4 by Rak3D is Fc
RI-regulated.
IgE-sensitized RBL-2H3 cells were stimulated with DNP-HSA (100 ng/ml)
for the indicated times. Proteins from cell lysates were
immunoprecipitated with anti-Rab3D and subjected to an IVK in the
presence of [
-32P]ATP and 10 µM
GST-syntaxin 4 fusion protein. Phosphorylated proteins were resolved on
10% SDS-PAGE and analyzed using a PhosphorImager. C, Rak3D
phosphorylates syntaxin 4 in Hb and Hc of the NH2-terminal
regulatory domain. Proteins from lysates of resting RBL-2H3 cells
(107 cells/sample) were immunoprecipitated with anti-Rab3D
and subjected to an IVK in the presence of [
-32P]ATP
and 10 µM GST-syntaxin 4 (GST-syntaxin 4) or the syntaxin
4 deletion mutants (GST-Ha, GST-Ha/Hb, and GST-Ha/Hb/Hc). The relative
location of each mutation is show in the schematic representation of
syntaxin 4 modeled after the structure of syntaxin 1. The histogram
shows a quantitative determination of relative phosphorylation levels
for the different mutants (mean ± S.E.) from five independent
experiments using ImageQuant Software. The asterisk
indicates statistical significant differences between mutants
(p < 0.05, Wilcoxon test).
-32P]ATP). The assay was designed to measure total
syntaxin 4 or phosphorylated syntaxin 4 binding to SNAP23. Recombinant
soluble syntaxin 4 devoid of GST was incubated with Rak3D to induce
phosphorylation. An aliquot of the reaction was incubated with
GST-SNAP23 prebound to glutathion-Sepharose. The bound and unbound
syntaxin 4 was determined by immunoblotting (total syntaxin 4) and by
PhosphorImager analysis (phosphorylated syntaxin 4). Fig.
5 shows the results of a representative
experiment and Table I summarizes the
data obtained from five independent experiments where different
concentrations of syntaxin 4 were added to the binding reaction. Based
on these results we determined that the binding of phosphorylated
syntaxin 4 to SNAP23 was inhibited by 70.6 ± 13.1% (mean ± S.E.). This demonstrates that the phosphorylation of syntaxin 4 by
Rak3D affects its ability to assemble with SNAP23.

View larger version (38K):
[in a new window]
Fig. 5.
Phosphorylation of syntaxin 4 by Rak3D
inhibits binding to SNAP23. Ten µM soluble
recombinant syntaxin 4 was used in an IVK with immunoprecipitated Rab3D
(107 cells). 0.3 µM of the phosphorylated
protein was incubated with 1.5 µM GST-SNAP23 bound to
gutathione-Sepharose beads for 1 h at 4 °C. Proteins in the
supernatant and bound materials were resolved by SDS-PAGE and analyzed
using a PhosphorImager (phospho syn4) or by immunoblotting
using a syntaxin 4-specific antibody (total syn4). Data
presented correspond to experiment 3 in Table I.
Effect of syntaxin 4 phosphorylation by Rak3D on SNAP23 binding

View larger version (27K):
[in a new window]
Fig. 6.
Syntaxin 4 is phosphorylated in RBL-2H3 mast
cells. IgE-sensitized RBL-2H3 cells were labeled with 330 µCi/ml
32P stimulated with 100 ng/ml DNP-HSA for 5 min or were
left unstimulated. Labeled proteins were immunoprecipitated using
specific antibodies to syntaxin 4 and Syk tyrosine kinase and analyzed
by autoradiography after migration on SDS-PAGE and transfer onto a
nitrocellulose membrane. The membrane was subsequently blotted with
anti-syntaxin 4 antibody. Labeled immunoprecipitated species are
specific as they cannot be detected in the respective
immunoprecipitates performed with the other antibody.
![]()
DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES
RI stimulation. The kinetic was
reproduced after stimulation with PMA/ionomycin indicating that the
kinase is regulated by a late signaling step independent of
receptor-proximal events. Use of pharmacological agents like
wortmannin, bisindolylmaleimide I, and EGTA, which block degranulation
by different mechanisms, revealed that only EGTA inhibited the observed
decrease demonstrating the critical role of calcium influx in
regulating Rak3D. Although evidence exists in several systems that the
action of Rab proteins requires activation of PI 3-kinase, by notably
providing membrane attachments sites for effectors (18), our data using
wortmannin suggest that PI 3-kinase is not necessary for regulation of
Rak3D. Similarly, PKC activation, which is important in mast cell
secretion (49), did not seem to regulate Rak3D, as inhibition with
bisindolylmaleimide I had no effect on Rak3D.
RI-dependent downmodulation.3 The easiest
explanation would be that the association of the kinase may not
necessarily depend on the nucleotide-bound state of Rab3D. In this
context, it has been recently demonstrated that lipid-modified Rab3A
can bind to calcium/calmodulin (Ca2+/CaM) in the presence
of either GDP or GTP via a Rab3-conserved basic amino acid sequence
(29). This interaction caused the dissociation of Rab3A from its target
membrane (29, 30). Thus, it is possible that Fc
RI engagement induces
the dissociation of Rab3D from Rak3D by a similar
calcium/CaM-dependent mechanism.
RI triggering (60). Although the molecular targets of this
phosphatase recruitment are not known it could serve to dephosphorylate
syntaxin 4 thereby facilitating membrane fusion. In our in
vivo labeling experiments we were, however, unable to observe an
apparent change in the syntaxin 4 phosphorylation status following
stimulation. A probable explanation may be that dephosphorylation could
concern only a small fraction of phosphorylated syntaxin 4 molecules at a given time. Previous analysis of SNARE-mediated-fusion processes in
yeast have indeed suggested that regulatory mechanisms occur locally,
are transient in nature, and include only a small proportion (<2%) of
all SNARE molecules (61). An additional reason may be that syntaxin 4 can be phosphorylated at multiple sites and that dephosphorylation at a
precise residue might occur following stimulation and be functionally
important without dramatically affecting the overall phosphorylation
level of the total cellular protein.
| |
Acknowlegments |
|---|
We thank Dr. C. Guérin-Marchand and Dr. M. Roa for discussions and advice. We are grateful to Dr. M. Benhamou for critical reading of the manuscript, R. Peronet for help in preparing polyclonal antibodies, and Valentino Paravinci for help in [32P] in vivo labeling. We also thank Dr. P. Alzari for insights on the potential phosphorylation sites in the homologues syntaxin 1 crystal structure and Vincenzo Di Bartolo for help with the phosphamino acid analysis.
| |
FOOTNOTES |
|---|
* This work was supported in part by the Institut Pasteur.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
§ Supported by a PRAXIS XXI fellowship (Ministério da Ciência e Tecnologia, Portugal).
To whom correspondence should be addressed: Institut Pasteur,
Unité d'Immuno-Allergie, 25-28 rue du Dr. Roux, 75724 Paris Cedex 15. Tel.: 33-1-40-61-32-64; Fax: 33-1-40-61-31-60; E-mail: ublank@pasteur.fr.
Published, JBC Papers in Press, September 12, 2001, DOI 10.1074/jbc.M103527200
2 SNAREs were originally divided into t-SNAREs and v-SNAREs according to their target or vesicle membrane localization. A second terminology has been proposed to avoid ambiguity in the case of homotypic membrane fusion. Thus, t-SNAREs have been reclassified as Q-SNAREs (Glu-containing SNARES) and R-SNARES (Arg-containing SNAREs), based on the identity of a highly conserved residue.
3 I. Pombo and U. Blank, unpublished data.
| |
ABBREVIATIONS |
|---|
The abbreviations used are:
Fc
RI, type I high
affinity IgE receptor;
Ca2+/CaM, calcium/calmodulin;
CaMKII, Ca2+/calmodulin-dependent protein
kinase II;
DNP, dinitrophenyl;
GST, glutathione
S-transferase;
HSA, human serum albumin;
IGKA, in-gel kinase
assay;
IVK, in vitro immune complex kinase assay;
MBP, myelin basic protein;
PAGE, polyacrylamide gel electrophoresis;
PI
3-kinase, phosphatidylinositol 3-kinase;
PMA, phorbol 12-myristate
13-acetate;
Rak3D, Rab3D associated kinase;
RBL-2H3, rat basophilic
leukemia cells;
SNAP23 or 25, synaptosome-associated protein of 23 kDa
or 25 kDa;
SNARE, soluble N-ethylmaleimide attachment
protein receptor;
Syn, syntaxin;
VAMP, vesicle-associated membrane
protein;
Pipes, 1,4-piperazinediethanesulfonic acid.
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Galli, S., and Lantz, C. S. (1998) in Fundamental Immunology (Paul, W., ed), 4th Ed. , pp. 1127-1174, Raven Press, New York |
| 2. | Röhlich, P., Anderson, P., and Uvnäs, B. (1971) J. Cell Biol. 51, 465-483 |
| 3. | Alvarez De Toledo, G., Fernandez-Chacon, R., and Fernandez, J. (1993) Nature 363, 554-558[CrossRef][Medline] [Order article via Infotrieve] |
| 4. |
Kim, T.,
Eddlestone, G.,
Mahmoud, S.,
Kuchtey, J.,
and Fewtrell, C.
(1997)
J. Biol. Chem.
272,
31225-31229 |
| 5. | Kinet, J. P. (1999) Annu. Rev. Immunol. 17, 931-972[CrossRef][Medline] [Order article via Infotrieve] |
| 6. | Williams, R. M., and Webb, W. W. (2000) J. Cell Sci. 113, 3839-3850[Abstract] |
| 7. | Söllner, T., Whiteheart, S. W., Brunner, M., Erdjument-Bromage, H., Geromanos, S., Tempst, P., and Rothman, J. E. (1993) Nature 362, 318-324[CrossRef][Medline] [Order article via Infotrieve] |
| 8. | Jahn, R., and Südhof, T. C. (1999) Annu. Rev. Biochem. 68, 863-911[CrossRef][Medline] [Order article via Infotrieve] |
| 9. | Bock, J. B., Matern, H. T., Peden, A. A., and Scheller, R. H. (2001) Nature 409, 839-841[CrossRef][Medline] [Order article via Infotrieve] |
| 10. | Chen, Y. A., and Scheller, R. H. (2001) Nat. Rev. Mol. Cell. Biol. 2, 98-106[CrossRef][Medline] [Order article via Infotrieve] |
| 11. | Gonzalez, L., Jr., and Scheller, R. H. (1999) Cell 96, 755-758[CrossRef][Medline] [Order article via Infotrieve] |
| 12. | Darchen, F., and Goud, B. (2000) Biochimie 82, 375-384[Medline] [Order article via Infotrieve] |
| 13. | Guo, Z., Turner, C., and Castle, D. (1998) Cell 94, 537-548[CrossRef][Medline] [Order article via Infotrieve] |
| 14. |
Paumet, F.,
Le Mao, J.,
Martin, S.,
Galli, T.,
David, B.,
Blank, U.,
and Roa, M.
(2000)
J. Immunol.
164,
5850-5857 |
| 15. |
Baram, D.,
Adachi, R.,
Medalia, O.,
Tuvim, M.,
Dickey, B. F.,
Mekori, Y. A.,
and Sagi-Eisenberg, R.
(1999)
J. Exp. Med.
189,
1649-1658 |
| 16. | Roa, M., Paumet, F., Le Mao, J., David, B., and Blank, U. (1997) J. Immunol. 159, 2815-2823[Abstract] |
| 17. | Demo, S. D., Masuda, E., Rossi, A. B., Throndset, B. T., Gerard, A. L., Chan, E. H., Armstrong, R. J., Fox, B. P., Lorens, J. B., Payan, D. G., Scheller, R. H., and Fisher, J. M. (1999) Cytometry 36, 340-348[CrossRef][Medline] [Order article via Infotrieve] |
| 18. | Zerial, M., and McBride, H. (2001) Nat. Rev. Mol. Cell. Biol. 2, 107-117[CrossRef][Medline] [Order article via Infotrieve] |
| 19. |
Takai, Y.,
Sasaki, T.,
and Matozaki, T.
(2001)
Physiol. Rev.
81,
153-208 |
| 20. | Waters, M. G., and Pfeffer, S. R. (1999) Curr. Opin. Cell Biol. 11, 453-459[CrossRef][Medline] [Order article via Infotrieve] |
| 21. | Geppert, M., Goda, Y., Stevens, C., and Südhof, T. (1997) Nature 387, 810-814[CrossRef][Medline] [Order article via Infotrieve] |
| 22. |
Doussau, F.,
Clabecq, A.,
Henry, J. P.,
Darchen, F.,
and Poulain, B.
(1998)
J Neurosci.
18,
3147-3157 |
| 23. |
Schimmoller, F.,
Simon, I.,
and Pfeffer, S. R.
(1998)
J. Biol. Chem.
273,
22161-22164 |
| 24. | Nielsen, E., Severin, F., Backer, J. M., Hyman, A. A., and Zerial, M. (1999) Nat. Cell Biol. 1, 376-382[CrossRef][Medline] [Order article via Infotrieve] |
| 25. |
Echard, A.,
Jollivet, F.,
Martinez, O.,
Lacapere, J. J.,
Rousselet, A.,
Janoueix-Lerosey, I.,
and Goud, B.
(1998)
Science
279,
580-585 |
| 26. | Johannes, L., Lledo, P. M., Chameau, P., Vincent, J. D., Henry, J. P., and Darchen, F. (1998) J. Neurochem. 71, 1127-1133[Medline] [Order article via Infotrieve] |
| 27. | Oberhauser, A., Balan, V., Fernandez-Badilla, C., and Fernandez, J. (1994) FEBS Lett. 339, 171-174[CrossRef][Medline] [Order article via Infotrieve] |
| 28. |
Tuvim, M. J.,
Adachi, R.,
Chocano, J. F.,
Moore, R. H.,
Lampert, R. M.,
Zera, E.,
Romero, E.,
Knoll, B. J.,
and Dickey, B. F.
(1999)
Am. J. Resp. Cell Mol. Biol.
20,
79-89 |
| 29. |
Park, J. B.,
Farnsworth, C. C.,
and Glomset, J. A.
(1997)
J. Biol. Chem.
272,
20857-20865 |
| 30. | Coppola, T., Perret-Menoud, V., Luthi, S., Farnsworth, C. C., Glomset, J. A., and Regazzi, R. (1999) EMBO J. 18, 5885-5891[CrossRef][Medline] [Order article via Infotrieve] |
| 31. |
Yamaguchi, T.,
Shirataki, H.,
Kishida, S.,
Miyazaki, M.,
Nishikawa, J.,
Wada, K.,
Numata, S.,
Kaibuchi, K.,
and Takai, Y.
(1993)
J. Biol. Chem.
268,
27164-27170 |
| 32. |
Haynes, L. P.,
Evans, G. J.,
Morgan, A.,
and Burgoyne, R. D.
(2001)
J. Biol. Chem.
276,
9726-9732 |
| 33. | Wang, Y., Okamoto, M., Schmitz, F., Hofmann, K., and Südhof, T. (1997) Nature 388, 593-598[CrossRef][Medline] [Order article via Infotrieve] |
| 34. |
Duprez, V.,
Blank, U.,
Chretien, S.,
Gisselbrecht, S.,
and Mayeux, P.
(1998)
J. Biol. Chem.
273,
33985-33990 |
| 35. | Kameshita, I., and Fujisawa, H. (1989) Anal. Biochem. 183, 139-143[CrossRef][Medline] [Order article via Infotrieve] |
| 36. |
Adamczewski, M.,
Paolini, R.,
and Kinet, J. P.
(1992)
J. Biol. Chem.
267,
18126-18132 |
| 37. | Ley, S. C., Davies, A. A., Druker, B., and Crumpton, M. J. (1991) Eur. J. Immunol. 21, 2203-2209[Medline] [Order article via Infotrieve] |
| 38. |
Toullec, D.,
Pianetti, P.,
Coste, H.,
Bellevergue, P.,
Grand-Perret, T.,
Ajakane, M.,
Baudet, V.,
Boissin, P.,
Boursier, E.,
Loriolle, F.,
Duhamel, L.,
Charon, D.,
and Kirilovsky, J.
(1991)
J. Biol. Chem.
266,
15771-15781 |
| 39. |
Yano, H.,
Nakanishi, S.,
Kimura, K.,
Hanai, N.,
Saitoh, Y.,
Fukui, Y.,
Nomomura, Y.,
and Matsuda, Y.
(1993)
J. Biol. Chem.
268,
25846-25856 |
| 40. | Foster, L. J., Yeung, B., Mohtashami, M., Ross, K., Trimble, W. S., and Klip, A. (1998) Biochemistry 37, 11089-11096[CrossRef][Medline] [Order article via Infotrieve] |
| 41. | Risinger, C., and Bennett, M. K. (1999) J. Neurochem. 72, 614-624[CrossRef][Medline] [Order article via Infotrieve] |
| 42. | Misura, K. M. S., Scheller, R. H., and Weis, W. I. (2000) Nature 404, 355-362[CrossRef][Medline] [Order article via Infotrieve] |
| 43. | Turner, K. M., Burgoyne, R. D., and Morgan, A. (1999) Trends Neurosci. 22, 459-464[CrossRef][Medline] [Order article via Infotrieve] |
| 44. | Marash, M., and Gerst, J. E. (2001) EMBO J. 20, 411-421[CrossRef][Medline] [Order article via Infotrieve] |
| 45. |
Fujita, Y.,
Sasaki, T.,
Fukui, K.,
Kotani, H.,
Kimura, T.,
Hata, Y.,
Südhof, T.,
Scheller, R.,
and Takai, Y.
(1996)
J. Biol. Chem.
271,
7265-7268 |
| 46. | Marshall, M. S. (1995) FASEB J. 9, 1311-1318[Abstract] |
| 47. |
Yasui, Y.,
Amano, M.,
Nagata, K.,
Inagaki, N.,
Nakamura, H.,
Saya, H.,
Kaibuchi, K.,
and Inagaki, M.
(1998)
J. Cell Biol.
143,
1249-1258 |
| 48. |
Ren, M.,
Zeng, J.,
De Lemos-Chiarandini, C.,
Rosenfeld, M.,
Adesnik, M.,
and Sabatini, D. D.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
5151-5155 |
| 49. |
Nechushtan, H.,
Leitges, M.,
Cohen, C.,
Kay, G.,
and Razin, E.
(2000)
Blood
95,
1752-1757 |
| 50. |
Fukui, K.,
Sasaki, T.,
Imazumi, K.,
Matsuura, Y.,
Nakanishi, H.,
and Takai, Y.
(1997)
J. Biol. Chem.
272,
4655-4658 |
| 51. |
Wada, M.,
Nakanishi, H.,
Satoh, A.,
Hirano, H.,
Obaishi, H.,
Matsuura, Y.,
and Takai, Y.
(1997)
J. Biol. Chem.
272,
3875-3878 |
| 52. |
Martincic, I.,
Peralta, M. E.,
and Ngsee, J. K.
(1997)
J. Biol. Chem.
272,
26991-26998 |
| 53. | Low, S. H., Chapin, S. J., Weimbs, T., Komuves, L. G., Bennett, M. K., and Mostov, K. E. (1996) Mol. Biol. Cell 7, 2007-2018[Abstract] |
| 54. | Hackam, D. J., Rotstein, O. D., Bennett, M. K., Klip, A., Grinstein, S., and Manolson, M. F. (1996) J. Immunol. 156, 4377-4383[Abstract] |
| 55. | Olson, A., Knight, J., and Pessin, J. (1997) Mol. Cell. Biol. 17, 2425-2435[Abstract] |
| 56. |
Flaumenhaft, R.,
Croce, K.,
Chen, E.,
Furie, B.,
and Furie, B. C.
(1999)
J. Biol. Chem.
274,
2492-2501 |
| 57. | Dulubova, I., Sugita, S., Hill, S., Hosaka, M., Fernandez, I., Südhof, T. C., and Rizo, J. (1999) EMBO J. 18, 4372-4382[CrossRef][Medline] [Order article via Infotrieve] |
| 58. |
Tellam, J.,
Macaulay, S.,
McIntosh, S.,
Hewish, D.,
Ward, C.,
and James, D.
(1997)
J. Biol. Chem.
272,
6179-6186 |
| 59. |
Foletti, D. L.,
Lin, R.,
Finley, M. A.,
and Scheller, R. H.
(2000)
J. Neurosci.
20,
4535-4544 |
| 60. |
Ludowyke, R. I.,
Holst, J.,
Mudge, L. M.,
and Sim, A. T.
(2000)
J. Biol. Chem.
275,
6144-6152 |
| 61. | Ungermann, C., Sato, K., and Wickner, W. (1998) Nature 396, 543-548[CrossRef][Medline] [Order article via Infotrieve] |
| 62. |
Chung, S. H.,
Polgar, J.,
and Reed, G. L.
(2000)
J. Biol. Chem.
275,
25286-25291 |